1-12
Original Paper
The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome
Susan Stuckless, Patrick S. Parfrey, Michael O. Woods, Janet Cox and G. William Fitzgerald, et al.
13-19
Original Paper
The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC)
Johanne Geary, Huw J. W. Thomas, James Mackay, Huw Dorkins and Julian Barwell, et al.
21-34
Original Paper
Molecular diagnosis of neurofibromatosis type 1: 2 years experience
Siân Griffiths, Peter Thompson, Ian Frayling and Meena Upadhyaya
35-41
ORIGINAL PAPER
Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden
Zakaria Einbeigi, Annika Bergman, Jeanne M. Meis-Kindblom, Anna Flodin and Cecilia Bjursell, et al.
43-51
Original Paper
The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family
Marjo van Puijenbroek, Maartje Nielsen, Tjitske H. C. M. Reinards, Marjan M. Weiss and Anja Wagner, et al.
53-62
Original Paper
Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies
R. C. Green, J. S. Green, S. K. Buehler, J. D. Robb and D. Daftary, et al.
63-71
Original Paper
Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred
Florian D. Vogl, Mike D. Badzioch, Linda Steele, Susan L. Neuhausen and David E. Goldgar
73-79
Original Paper
Identification of a founder BRCA2 mutation in Sardinian breast cancer families
Maria Monne, Giovanna Piras, Patrizia Fancello, Maria Cristina Santona and Antonella Uras, et al.
81-87
Original paper
Familial colorectal cancer referral to regional genetics department—a single centre experience
Tony Mak, Douglas Speake, Fiona Lalloo, James Hill and D. G. R. Evans
89-95
Original Paper
An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients
Catherine F. Li, Robert Y. Wei, Frank Baliko, Bharati Bapat and Benjamin A. Alman
97-102
Original Paper
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy
Francesca Bianchi, Eva Galizia, Emilio Porfiri, Laura Belvederesi and Romina Catalani, et al.
103-111
Original Paper
Study comparing two types of screening provision for people with von Hippel-Lindau disease
Lindsay Fraser, Sally Watts, Anna Cargill, Stephen Sutton and Shirley Hodgson
113-119
Original Paper
Improved survival in BRCA2 carriers with ovarian cancer
Tuya Pal, Jenny Permuth-Wey, Rachna Kapoor, Alan Cantor and Rebecca Sutphen
121-129
Original Paper
The interval between cancer diagnosis among mothers and offspring in a population-based cohort
Ora Paltiel, Yehiel Friedlander, Lisa Deutsch, Rebecca Yanetz and Ronit Calderon-Margalit, et al.
131-134
Original Paper
Open AccessFamily history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data
D. A. van Dijk, M. J. Oostindiër, W. M. Kloosterman-Boele, P. Krijnen and H. F. A. Vasen, et al.
135-140
Utility of computed tomographic colonography in surveillance for hereditary nonpolyposis colorectal cancer syndrome
Laura Renkonen-Sinisalo, Arto Kivisaari, Leena Kivisaari, Seppo Sarna and Heikki J. Järvinen
141-145
Case Report
A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene
M. Vernez, P. Hutter, C. Monnerat, N. Halkic and O. Gugerli, et al.
147-152
Brief communication
Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene
W. Stewart, J. P. Traynor, A. Cooke, S. Griffiths and N. F. Őnen, et al.
153-157
Short Communication
Heterozygote BRCA1 status and skewed chromosome X inactivation
Anne Helbling-Leclerc, Gilbert M. Lenoir and Jean Feunteun
159
Erratum
Acceptance of preventive surgeries by Israeli women
who had undergone BRCA testing
Vardit Kram, Tamar Perez and Michal Sagi